Search Results for: Semma

ViaCyte & CRISPR Therapeutics team up to battle diabetes

September 17, 2018 February 1, 2021 / By Professor Paul Knoepfler, Ph.D. / 2 Comments

What happens when one of the most exciting stem cell biotechs ViaCyte teams up with a firm like CRISPR Therapeutics to use a combination of gene editing and cell therapy? Hopefully a synergistic partnership emerges that in this case can develop an effective stem cell-based therapy for diabetes. You can see a press release on …

ViaCyte & CRISPR Therapeutics team up to battle diabetes Read More »

Stem cell good news for the holidays: biotechs, FDA, organoids

December 7, 2017 February 1, 2021 / By Professor Paul Knoepfler, Ph.D.

Atsuhiro-Taguchi-and-Ryuichi-Nishinakamura-part-of-Figure-4-Cell-Stem-Cell-2017

I can see many reasons to be jolly on the regenerative medicine front as we get deeper into the holiday season as there is quite a lot of stem cell good news even if there is also some not so good news. In today’s post the focus is on the good news of late. Semma …

Stem cell good news for the holidays: biotechs, FDA, organoids Read More »